Analyzing the signals in some cases using machine learning may identify cancers early and enable patients to receive treatment while their chances of longterm survival are high. Flagship Pioneering the venture capital fund that created Moderna launched Harbinger in 2020 believing that it has a better approach to multicancer early detection